AU2022230780B2 - Chromosome interaction markers - Google Patents

Chromosome interaction markers Download PDF

Info

Publication number
AU2022230780B2
AU2022230780B2 AU2022230780A AU2022230780A AU2022230780B2 AU 2022230780 B2 AU2022230780 B2 AU 2022230780B2 AU 2022230780 A AU2022230780 A AU 2022230780A AU 2022230780 A AU2022230780 A AU 2022230780A AU 2022230780 B2 AU2022230780 B2 AU 2022230780B2
Authority
AU
Australia
Prior art keywords
cancer
superpath
obd189
lung
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2022230780A
Other languages
English (en)
Other versions
AU2022230780A1 (en
Inventor
Alexandre Akoulitchev
Ewan HUNTER
Aroul Selvam Ramadass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biodynamics PLC
Original Assignee
Oxford Biodynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biodynamics PLC filed Critical Oxford Biodynamics PLC
Publication of AU2022230780A1 publication Critical patent/AU2022230780A1/en
Application granted granted Critical
Publication of AU2022230780B2 publication Critical patent/AU2022230780B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022230780A 2021-03-04 2022-03-03 Chromosome interaction markers Active AU2022230780B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163156659P 2021-03-04 2021-03-04
US63/156,659 2021-03-04
US202163282284P 2021-11-23 2021-11-23
US63/282,284 2021-11-23
PCT/GB2022/050561 WO2022185062A1 (en) 2021-03-04 2022-03-03 Chromosome interaction markers

Publications (2)

Publication Number Publication Date
AU2022230780A1 AU2022230780A1 (en) 2023-10-12
AU2022230780B2 true AU2022230780B2 (en) 2024-05-23

Family

ID=80735500

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022230780A Active AU2022230780B2 (en) 2021-03-04 2022-03-03 Chromosome interaction markers

Country Status (15)

Country Link
US (1) US20240229135A9 (enExample)
EP (1) EP4301874B1 (enExample)
JP (1) JP2024511292A (enExample)
KR (1) KR20240006020A (enExample)
AU (1) AU2022230780B2 (enExample)
BR (1) BR112023017802A2 (enExample)
CA (1) CA3209544A1 (enExample)
ES (1) ES3029416T3 (enExample)
GB (1) GB2618727B (enExample)
HU (1) HUE071359T2 (enExample)
IL (1) IL304883A (enExample)
PL (1) PL4301874T3 (enExample)
TW (1) TW202302862A (enExample)
WO (1) WO2022185062A1 (enExample)
ZA (1) ZA202309162B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019086898A2 (en) * 2017-11-03 2019-05-09 Oxford Biodynamics Limited Genetic regulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020198676A1 (en) * 2019-03-28 2020-10-01 Bristol-Myers Squibb Company Methods of treating tumor
GB2626699B (en) * 2019-05-08 2024-11-20 Oxford BioDynamics PLC Chromosome Conformation Markers of Prostate Cancer and Lymphoma
WO2021228888A1 (en) * 2020-05-12 2021-11-18 Asylia Diagnostics Biomarkers for hyperprogressive disease and therapy response after immunotherapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019086898A2 (en) * 2017-11-03 2019-05-09 Oxford Biodynamics Limited Genetic regulation

Also Published As

Publication number Publication date
JP2024511292A (ja) 2024-03-13
US20240229135A9 (en) 2024-07-11
BR112023017802A2 (pt) 2023-12-12
TW202302862A (zh) 2023-01-16
AU2022230780A1 (en) 2023-10-12
EP4301874C0 (en) 2025-04-23
HUE071359T2 (hu) 2025-08-28
ES3029416T3 (en) 2025-06-24
EP4301874B1 (en) 2025-04-23
GB202313067D0 (en) 2023-10-11
WO2022185062A1 (en) 2022-09-09
ZA202309162B (en) 2025-03-26
GB2618727A (en) 2023-11-15
US20240132959A1 (en) 2024-04-25
PL4301874T3 (pl) 2025-06-23
GB2618727B (en) 2024-07-17
KR20240006020A (ko) 2024-01-12
CA3209544A1 (en) 2022-09-09
EP4301874A1 (en) 2024-01-10
IL304883A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
US12412639B2 (en) Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples
JP7631400B2 (ja) 遺伝子調節
AU2016330780A1 (en) Immunorepertoire normality assessment method and its use
US20260002208A1 (en) Chromosome interactions
EP4301874B1 (en) Chromosome interaction markers
AU2021286282B2 (en) Chromosome conformation markers of prostate cancer and lymphoma
AU2021283746B2 (en) Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma
EP4137585A1 (en) Cancer informative biomarker signature
CN117795098A (zh) 染色体相互作用标志物
EP4225945A1 (en) Disease marker
WO2019206217A1 (zh) 多发性骨髓瘤分子分型及应用
AU2024344411A1 (en) Chromosome detection assay
HK40084342A (en) Immunorepertoire normality assessment method and its use
HK40033107A (en) Genetic regulation of immunoresponse by chromosome interactions
HK40033107B (en) Genetic regulation of immunoresponse by chromosome interactions

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)